0001567619-21-011842.txt : 20210608
0001567619-21-011842.hdr.sgml : 20210608
20210608171136
ACCESSION NUMBER: 0001567619-21-011842
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210606
FILED AS OF DATE: 20210608
DATE AS OF CHANGE: 20210608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lanfear Dennis M
CENTRAL INDEX KEY: 0001420822
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36721
FILM NUMBER: 211002988
MAIL ADDRESS:
STREET 1: C/O COHERUS BIOSCIENCES, INC.
STREET 2: 333 TWIN DOLPHIN DRIVE, SUITE 600
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Coherus BioSciences, Inc.
CENTRAL INDEX KEY: 0001512762
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 273615821
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: C/O DENNIS M. LANFEAR
STREET 2: 333 TWIN DOLPHIN DR, SUITE 600
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: (650) 649-3530
MAIL ADDRESS:
STREET 1: C/O DENNIS M. LANFEAR
STREET 2: 333 TWIN DOLPHIN DR, SUITE 600
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
FORMER COMPANY:
FORMER CONFORMED NAME: BioGenerics, Inc.
DATE OF NAME CHANGE: 20110210
4
1
doc1.xml
FORM 4
X0306
4
2021-06-06
0
0001512762
Coherus BioSciences, Inc.
CHRS
0001420822
Lanfear Dennis M
COHERUS BIOSCIENCES, INC.
333 TWIN DOLPHIN DRIVE, SUITE 600
REDWOOD CITY
CA
94065
1
1
0
0
President & CEO
Common Stock
2021-06-06
4
M
0
300000
0.4168
A
493258
D
Common Stock
2021-06-08
4
M
0
31054
0.4168
A
524312
D
Common Stock
2021-06-08
4
S
0
31054
13.5644
D
493258
D
Common Stock
446684
I
By Trust
Common Stock
86965
I
By LLC
Stock Option (Right to Buy)
0.4168
2021-06-06
4
M
0
300000
0.00
D
2021-07-17
Common Stock
300000
31054
D
Stock Option (Right to Buy)
0.4168
2021-06-08
4
M
0
31054
0.00
D
2021-07-17
Common Stock
31054
0
D
These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee.
These shares are held by Lanfear Capital Advisors, LLC of which Reporting Person is President.
The transaction was executed in multiple trades in prices ranging from $13.55 to $13.61, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
The shares underlying this option are fully vested and exercisable as of the date hereof.
/s/ McDavid Stilwell, as Attorney-in-Fact for Dennis M. Lanfear
2021-06-08